Latest news
ALS Director Malcolm Deane Receives New Performance Rights Under 2026 LTI Plan - TipRanksTipRanks · Sat, 08 Aug 2026 16:21:51 GMTRactigen Reaches Key Phase II Milestone for RAG-17 in SOD1-ALS Program - TipRanksTipRanks · Thu, 06 Aug 2026 12:30:52 GMTVeritas In Silico Expands mRNA Partnerships as ALS Drug and Delivery Pipeline Advance - TipRanksTipRanks · Wed, 05 Aug 2026 15:01:35 GMTALS CEO sells shares to cover tax on incentive awards - TipRanksTipRanks · Wed, 05 Aug 2026 09:38:09 GMTRactigen Therapeutics – Weekly Recap - TipRanksTipRanks · Sat, 01 Aug 2026 16:38:52 GMTNeurizon accelerates ALS trial and secures supply deal as funding base strengthens - TipRanksTipRanks · Fri, 31 Jul 2026 06:08:28 GMTCorcept Therapeutics Raises 2026 Revenue Outlook on Momentum - The Globe and MailThe Globe and Mail · Thu, 30 Jul 2026 20:50:00 GMTNeurizon to Outline ALS Trial Progress and NUZ-001 Strategy at Melbourne Investor Briefing - TipRanksTipRanks · Wed, 29 Jul 2026 04:15:29 GMT